Objective: Redox stress, c-Abl activation, and α -synuclein aggregates each independently contribute to neurodegeneration in Parkinson's disease. Interactions between these factors may underlie convergent and feed-forward mechanisms of disease progression.
INTRODUCTION
Risk factors for Parkinson's disease (PD) include exposure to toxins and environmental agents that affect cell redox state, such as MPTP, rotenone, paraquat, and others [1] [2] [3] . Risk for PD is also increased by genetic variants that promote formation of α -synuclein aggregates 4 . These environmental and genetic factors can interact, as redox state influences α -synuclein aggregation 3, 5, 6 and, conversely, α -synuclein aggregates induce oxidative stress 7, 8 . These bidirectional interactions suggest the possibility of convergent or feed-forward relationships that could be targeted to suppress disease progression. However, the mechanisms by which these factors interact in vivo is not well understood.
The tyrosine kinase c-Abl provides one potential link between cell redox state and α synuclein aggregation. c-Abl is a ubiquitous non-receptor protein kinase. It normally functions as part of the cellular DNA damage response 9 , but mutations in c-Abl that cause constitutive activation contribute to myeloproliferative and other cancer types 10 . Cell culture studies suggest that c-Abl can be activated by oxidative stress, although it is uncertain if this is a direct effect or an indirect effect of DNA damage [11] [12] [13] . In animal models of PD, c-Abl activation promotes both α -synuclein aggregate formation and neuronal death 13, 14 . The effect of c-Abl on aggregate formation is mediated in part by its phosphorylation of the ubiquitin ligase, parkin, as phosphorylated parkin is unable to ubiquitinate substrates such as α -synuclein and thus slows their normal proteolysis 15, 16 . c-Abl may also promote aggregate formation through direct phosphorylation of α -synuclein at residue 39 14, 17 .
Pharmacological inhibition of c-Abl can slow disease progression in animal models of PD 13, 18 , and a clinical trial of c-Abl inhibitor, nilotinib, is currently underway. However, nilotinib and other c-Abl inhibitors as a class exhibit significant cardiac, gastrointestinal and other toxicities 19 , which may limit their use in chronic diseases such as PD.
Here we sought to determine whether c-Abl activation mediates interaction between redox stress and α -synuclein aggregate formation, and whether suppressing redox stress can suppress the effects of c-Abl on α -synuclein aggregation. We used cell culture and two mouse models of PD; stereotactic injection of pre-formed α -synuclein fibrils, and AAVmediated α -synuclein overexpression. Our findings show that α -synuclein aggregates activate c-Abl through an oxidant stress mechanism that can be blocked by the thiol agent N-acetyl cysteine (NAC) . Surprisingly, NAC also suppressed formation of α -synuclein aggregates. The results identify a feed-forward mechanism by which α -synuclein aggregates can drive c-Abl activation, and support accumulating evidence that N-acetyl cysteine could be an effective therapeutic intervention for PD.
MATERIALS and METHODS
All studies were performed in accordance with the US PHS Policy on Humane Care and Use of Laboratory Animals and with protocols approved by the San Francisco Aliquots were thawed and sonicated for 5 minutes immediately before use. rAAV production Recombinant AAV genomes were generated by inserting full length human synuclein or mCherry behind the CAG (CBA/CMV hybrid) promoter and packaged in rAAV2/9 as described 21 . In brief, 293T cells were transfected with genome and helper plasmids. Three days later, virus was harvested from media and cells and purified using an idodixanol gradient. Virus was quantified using digital droplet PCR, and titers were diluted to 1.0 x 10 13 vector genomes / ml.
Cell culture studies
Neurons were isolated from embryonic day 17 / 18 of C57BL/6 wildtype or α , β ,γ synuclein triple knockout mice 22 and plated onto poly-D-lysine coated glass coverslips as described 23 . The cultures were maintained in medium containing 5 mM glucose, with Neurobasal (Life technologies #21103049), and B27 (Life technologies #17504044) supplements, in a 5% CO 2 , 37 o C incubator. Exposure to PFFs was performed by adding 1 µg / ml to culture media of neurons on day 7 in vitro. Where used, N-acetyl cysteine (NAC, 400 µM) was added on day 9 in vitro at a 400 µM concentration.
Immunostaining and live-cell assessment of reactive oxygen species with dihydroethidium were performed as described 23 . Three to five photos were taken of each coverslip by an observer blinded to the experimental conditions, and with identical camera settings maintained within each experiment. Fluorescence intensity was measured as arbitrary units and normalized to either the number of cells or neuronal area in each field. For live-cell assessment of reactive oxygen species, 10 µM dihydroethidium (Life Technologies, D11347) was added to the culture medium 30 minutes prior to fixation.
Cells were lysed in Phospho-Sure lysis buffer and the tissue lysate was then sonicated on ice, agitated on a rotator at 4 ºC for 1 hour, and centrifuged for 30 minutes at 4ºC, 10,000 g. Proteins in the supernatant were separated by electrophoresis and transferred to PVDF membranes. The membranes were then blocked with 5% non-fat milk or goat serum, incubated with primary antibody overnight, with secondary antibody (IR 600/800 CW, Licor, #C70908-04 or #C70620-05) for 1 hour, and imaged on an Odyssey gel scanner. Where chemiluminescence imaging was used, membranes were incubated with secondary antibodies (Sigma, Rabbit-GENA934 and Mouse-GENA931) and treated with Pierce Super signal reagent (ThermoFisher #34580). For immunoblots of α -synuclein oligomers 24 ,1% SDS was added to the cell lysates, the lysates were centrifuged at 16,000 g, and the PVDF membranes were treated with paraformaldehyde prior to immunoblotting 24 .
Mouse studies
The in vivo studies used either wild-type C57Bl/6 mice or EAAC1 -/male mice 25 on the C57BL/6 background. Mice were arbitrarily assigned to treatment groups at age 9 months and euthanized at age 15 months. Where used, N-acetyl cysteine (NAC) was provided in drinking water at a concentration of 3 mg / ml, and exchanged twice weekly with fresh solution. Of the 26 mice used for the studies there were two premature mortalities, both in the AAV-synuclein group. Behavioral assessments. The rota-rod test and pole tests were performed as described 27, 28 , with minor modifications. Two persons handled the mice, and both were blinded to the treatment group assignments. For the rota-rod test, mice were first habituated to the task by placement for 90 seconds on a horizontal rod (San Diego Instruments Rota-rod) rotating at 4 rpm (1 st day) and 5.5 rpm (2 nd day), 5 times each day. For testing, mice were placed on the horizontal rod at a start speed 0 rpm and an acceleration rate of 6 rpm / minute, and the time until fall from the rod was recorded.
Tests were repeated 6 times each day for 2 consecutive days. The outlier (low value) for each mouse was discarded and the average time from the remaining 11 trials was recorded for each mouse. For the pole test, mice were placed face-up at the top of a pole (45 cm length, 1.2 cm diameter), wrapped in tape for grip. A piece of cardboard was fitted over the top of the pole so that the mouse had to turn face down to descend the pole. Each assessment involved 2 days of habituation followed by 3 days of testing. An experimenter guided the mouse to complete the task during habituation.
Testing was performed twice a day for three consecutive days and video was recorded.
The recordings were later analyzed by an observer who was also blinded to the treatment conditions and scored for turn-around time (time taken to face downward) and descent time (time taken to come down the pole). However, descent-time was not used for data analysis because some impaired mice were unable to descend the pole normally and instead either slid down or used their tails to assist. Timing was begun with the first mouse movement, and any time exceeding 3 seconds during which the mouse was motionless was subtracted from the total time. Times were averaged for each mouse over the 3 trials.
Brain harvest and tissue preparation. Mice were transcardially perfused with 200 ml of 0.9% cold saline and brains were removed. The brains were sagitally bisected. The right half was immersed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 48 hours, followed by immersion in 20% sucrose for 48 hours, and sectioned in a cryostat (40 μm thickness). The left half of the PFF bisected brains were stored at -80 ºC until use for immunoblot preparation. At that time, a 1.0 mm coronal section was isolated from the frozen hemi-brain at the level of the substantia nigra and homogenized in PhosphoSure lysis buffer containing Hank's phosphatase and protease inhibitor cocktail (ThermoScientific #78430). The tissue lysate was then sonicated on ice, and treated as described for the cell culture studies.
Immunohistochemistry. Sections were rinsed in PBS, then incubated in blocking buffer (10% goat serum and 0.1% Triton X-100 in 0.1 M PBS) for 1 hour at room temperature. The sections were then incubated with designated primary antibodies overnight in blocking buffer. After washing, the sections were incubated with secondary antibodies that were either biotinylated or coupled to fluorescent tags. Biotinylated IgG secondary antibody was used at 5 A stereological approach was used to assess tyrosine hydroxylase -positive neurons in the substantia nigra pars compacta. Three coronal sections were analyzed from each mouse, taken at the levels of -2.6, -3.2, and -3.6 mm anterior to Bregma, which nearly span the pars compacta 30 . Tyrosine hydroxylase -positive cell bodies were counted in the substantia nigra pars compacta (as defined by Fu et al. 30 ) in each brain hemisection. The cell counts were made by an observer blinded to experimental conditions, and the counts for each mouse were expressed as the average number of cells per hemisection.
Statistical analyses
For cell culture data, the "n" was defined as the number of experiments done using independent culture preparations, each with 3 -4 internal replicates. For mouse studies, "n" denotes the number of animals in each group. When two groups were compared, data was analyzed by 2-sided student's t test. For analyzing two or more groups, oneway ANOVA followed by the Bonferroni post hoc test for multiple comparisons.
GraphPad Prism 8.0 software was used for all statistical analyses.
RESULTS
We used cultured mouse neurons to investigate the relationships between 20 . Aggregate formation was accompanied by oxidative stress, as shown by formation of the lipid peroxidation product 4-hydroxynonenal (Fig. 1C, D) and by conversion of dihydroethidium to oxidized ethidium species (Fig. 3B ).
We assessed c-Abl activation in the PFF-exposed cultures by western blotting with antibodies to total c-Abl and activated c-Abl (phosphorylated at tyrosine 245) 14 .
Neurons incubated with PFFs showed a large increase in activated c-Abl, with no change in total c-Abl (Fig. 1E ). c-Abl activation in the PFF-exposed cells was further evidenced by a large increase in phospho-39 α -synuclein ( Fig. 1F) , which is produced by activated c-Abl 17 . Together, these results show that PFF-induced α -synuclein aggregates produce both oxidative stress and c-Abl activation in cultured neurons.
Oxidative stress alone is sufficient to activate c-Abl in culture and in vivo
To determine whether oxidative stress is sufficient to cause c-Abl activation in neurons, we exposed cultures to hydrogen peroxide. Western blots prepared from these cultures showed a robust increase in c-Abl activation ( Fig. 2A) . The H 2 O 2 -induced c-Abl activation was suppressed by N-acetyl-cysteine (NAC), a thiol agent previously shown to support neuronal glutathione synthesis 28, 31 and to have salutary effects in animal models of PD 28, 32, 33 . We next evaluated the effect of redox stress on c-Abl activation in vivo, using EAAC1 -/mice. EAAC1 (also termed EAAT3 and SLC1A1) is a neuronal cysteine transporter, and mice deficient in EAAC1 -/mice have reduced glutathione levels and chronic oxidative stress in neurons 25, 28 (Fig. 2B) . Western blot and immunofluorescence measures of phospho c-Abl in EAAC1 -/mouse cerebral cortex midbrain showed increased c-Abl activation, and additionally showed this to be prevented by administration of NAC (3mg / ml) in drinking water (Fig. 2C, D) , thus demonstrating that chronic oxidative stress is sufficient to drive neuronal c-Abl activation.
N-acetyl cysteine suppresses oxidant stress and c-Abl activation in cultured neurons
If the c-Abl activation induced by α -synuclein aggregates is mediated by oxidative stress, then suppression of oxidative stress should attenuate c-Abl activation in the PFF-treated neurons. This was tested by incubating the PFF -treated neuronal cultures with NAC. NAC reduced formation of both HNE and oxidized ethidium species (Fig 3A,   1  0 B), and also reduced formation of α -synuclein aggregates (Fig. 3C) . NAC also suppressed c-Abl activation, as demonstrated both by immunostaining and western blots ( Fig. 3D, E) . The effect of NAC was comparable to that achieved by the c-Abl inhibitor nilotinib, which is a targeted inhibitor of c-Abl 34 and included here as a positive control.
PFFs injections induce oxidative stress and c-Abl activation in vivo
We next evaluated effects of PFF-induced oxidative stress and c-Abl activation in mouse brain. Mice aged 9 -10 months received bilateral injections of PFFs (or saline control) into the substantia nigra 35 . NAC was added to the drinking water of half of the PFF-injected mice beginning 2 weeks after the injections and continued until brain harvest 6 months later. Assessment of the substantia nigra in these brains showed that PFF injections reduced neuronal glutathione content (indicative of redox stress) and that NAC attenuated this effect (Fig. 4 ). PFF injections also produced α -synuclein aggregation and lipid peroxidation in substantia nigra neurons (Fig. 4) . The aggregates and lipid peroxidation were prominent in dopaminergic (tyrosine hydroxylase (TH)positive) neurons, but not restricted to these cells. Mice treated with NAC exhibited a substantial reduction in lipid peroxidation (Fig. 4B, C) , indicating attenuated redox stress. These mice also showed suppression of c-Abl activation, as assessed by both phospho c-Abl formation and phospho-synuclein 39 formation (Fig. 4D, E) , thus indicating redox stress as the primary factor driving c-Abl activation. Surprisingly, there was also a substantial reduction in α -synuclein aggregate formation in the mice treated with NAC ( Fig. 4B, C) . Evaluation of TH -positive cells in the substantia nigra pars compacta showed a reduction in mice subjected to PFF injections, and this was accompanied by reduced performance on the rota-rod test and increased turn-around time on the pole test ( Fig. 5) . These impairments were also attenuated in the mice treated with NAC.
AAV-mediated α -synuclein overexpression induces oxidative stress and c-Abl activation
As a second mouse model of α -synuclein aggregate formation, we injected adenoassociated virus expressing human α -synuclein into the substantia nigra 36 . Controls were injected with AAV expressing mCherry ( Fig 6A) . NAC was added to the drinking water of half of the mice beginning 2 weeks after the AAV injections and continued until brain harvest 6 months later. Assessment of the substantia nigra in these brains showed that the AAV α -synuclein injections produced α -synuclein aggregates and oxidative stress, along with c-Abl activation (Fig. 6B, C) . Co-labeling for TH revealed phospho (activated) c-Abl in dopaminergic neurons (Fig. 6D ). Dopaminergic cell death could not be assessed in the substantia nigra of these mice because of insufficient material for stereological assessment. However, immunostaining for dopaminergic projections into the striatum showed a decrease in TH -positive innervation in brains injected with AAV-α-synuclein, and an attenuation of this decrease by NAC treatment (Fig. 6E) . As with the PFF injections, mice injected with AAV-α-synuclein also exhibited reduced motor dexterity as assessed by the rota-rod test and pole test, which were also attenuated by NAC treatment. α -synuclein aggregate formation, these results identify a potentially feed-forward process (Fig. 7) . Consistent with this idea, our findings also show that NAC suppresses the oxidant stress caused by α -synuclein aggregates, and that this likewise suppresses both c-Abl activation and aggregate formation itself.
DISCUSSION

Interactions between cell redox state and
Large, histochemically identifiable aggregates of α -synuclein (Lewy bodies) are a diagnostic feature of PD. These large aggregates are unlikely to be directly cytotoxic, but they are strongly associated with cytotoxicity that is putatively mediated by smaller, oligomeric aggregates or by products cleaved from aggregates 37 , or by sequestration of soluble α -synuclein 26 . Aggregate formation can be induced experimentally by exposure to pre-formed human α -synuclein fibrils (PFFs) through a putative prion-like mechanism 20, 38 . Here we used PFFs to induce formation of α -synuclein aggregates in neuronal cultures and in vivo. To complement the studies performed with PFFs, we also used an AAV-mediated α -synuclein overexpression approach, which likewise induces aggregate formation 39 . Both studies employed relatively old mice, age 9 -15 months, which are more prone to develop α -synuclein aggregates and better mimic human PD. Aggregates induced by both approaches produced redox stress and c-Abl activation. They also produced dopaminergic neurodegeneration and associated motor deficits. The severity of the motor deficits was modest, consistent with prior studies indicating relative preservation of motor function in mice with incomplete or unilateral injury to substantia nigra 40 .
c-Abl activation promotes the formation or stability of α -synuclein aggregates, and may thereby contribute to PD pathogenesis 13 . However, the trigger for c-Abl activation in PD has been uncertain. Cell culture studies cells indicate that oxidative stress can activate c-Abl by direct or indirect pathways [11] [12] [13] . Our findings confirm that oxidant stress is sufficient to induce c-Abl, both in neuronal cell cultures with acute exposure of H 2 O 2 , and in vivo using the EAAC1 -/mouse of chronic neuronal redox stress. The neuronal glutathione deficit and other phenotypic features of EAAC1 -/mice can be negated by oral NAC administration 28 , and the present results show that NAC treatment also blocks c-Abl activation in these mice.
The mechanism by which α -synuclein aggregates lead to redox stress was not evaluated in this study. Prior work suggests that this may occur through the interaction of aggregates or aggregate cleavage products with mitochondria 41, 42 or transition state metals in neuronal cytosol 7 . It is also possible that aggregates induce activation of NADPH oxidase, which produces superoxide and has been identified as a potential pathogenic factor in PD 43 .
Although NAC suppressed c-Abl activation both in cell culture and in vivo, the mode of NAC action may differ in the two settings. NAC administration in vivo supports synthesis of neuronal glutathione, which is used as a cofactor for enzyme-mediated protein repair and oxidant scavenging. Most glutathione is recycled, and consequently low CSF concentrations of NAC are sufficient to maintain neuronal glutathione levels 31 .
As demonstrated in the present study, 3 mg / ml of NAC in water was sufficient to maintain normal glutathione levels in neurons containing α -synuclein aggregates.
Neurons in culture have ready access to cysteine and cystine in the culture medium, and in this setting the anti-oxidant effect of NAC is independent of glutathione synthesis and attributable to direct oxidant scavenging by its reactive cysteine thiol, which requires a higher NAC concentration 44 . NAC may also have additional actions on neurons mediated by its effects on cell redox state or ferroptosis 45 .
NAC also reduced formation of α -synuclein aggregates both in the cell culture and the in vivo models of PD. While the reduced aggregate formation is relevant to PD therapeutics, this also makes it difficult to ascertain whether the associated reduction in oxidant stress and dopaminergic neurodegeneration were direct effects of NAC, or indirect effects mediated by the reduced aggregate formation. However, given the feedforward relationships between these events (Fig. 7) , a distinction between these two alternatives may not be meaningful.
Glutathione levels are decreased selectively in the substantia nigra pars compacta (SNc) of patients with PD and presumed pre-symptomatic PD 46, 47 , and studies using animal models suggest that this reduction contributes to disease progression 28, 48, 49 . In accordance with this idea, NAC has been shown to have beneficial effects in both toxin and genetic models of PD 28, 32, 33 . NAC is inexpensive, FDA-approved, orally absorbed, and crosses the blood-brain barrier 28, 31 . Thiol repletion using NAC or other agents has been repeatedly cited as a promising approach for slowing PD progression 31, 46, 50 , and results of the present study provide additional mechanistic support for this approach. 
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